Open Accessc-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
Author(s) -
ShuHui Lin,
HsinKai Wang,
KunTu Yeh,
Huichun Tai,
HuiYi Wang,
Lan-Ru Huang,
Chun-Wen Chiu,
ChiaMin Chung,
Bharath Kumar Velmurugan
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s225782
Subject(s) - medicine , hazard ratio , ethics committee , stage (stratigraphy) , proportional hazards model , oncology , basal cell , cancer , family medicine , cancer research , confidence interval , biology , paleontology , public administration , political science
The authors advised that firstly, they incorrectly listed the CCH IRB number on page 5164. Therefore, the sentence “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170143).” should instead read “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170413).” The authors advised that secondly, they incorrectly listed the wrong protein name in Table 3 on page 5167. This was the result of a typing error when they reviewed the manuscript. The title “The effect of clinicopathologic factor and UNC13C expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients” should instead read “The effect of clinicopathologic factor and c-MYC expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients.”
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom